Alpharma Withdraws Embeda NDA

Resubmission is planned shortly; launch of the abuse-deterrent painkiller remains on track for first quarter 2009.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet